Centre-State lack of coordination delivers medical supply chain sucker punch
MTaI urges states to unblock medical device manufacturing and transport during lockdown, warning supply disruptions weaken hospital COVID-19 preparedness.
Read More
State govts, local administrors should urgently revive med devices supply chain: MTaI
MTaI urges states to restore medical device supply chains during lockdown, warning disruptions weaken hospital preparedness against COVID-19.
Read More
Medical tech sine-qua-non in COVID-19 management till vaccine / drug is developed
MTaI urges urgent govt action to keep medical device supply chains moving during COVID-19, seeking customs priority, worker exemptions and courier access.
Read More
Budget 2020: Cess on imported medical devices to lead to cost escalation for patient, says MTaI
MTaI warns Budget 2020’s 5% health cess on imported medical devices will raise costs, hurt affordability, and undermine PMJAY goals.
Read More
Quick government interventions have eased some of the major operational challenges: MTaI
MTaI is working with the government to ease lockdown bottlenecks, restore supply chains, and ensure uninterrupted medical device supply for COVID-19 care.
Read More
MTaI urges govt to maintain liquidity in healthcare sector
MTaI urges tax deferrals and financial relief to protect healthcare liquidity, as COVID-19 strains the entire MedTech and hospital value chain.
Read More
Govt has begun to acknowledge financial pressures on medical device firms: MTaI
MTaI welcomes govt nod allowing 10% knee implant price hike, citing relief from currency depreciation, inflation, and prolonged price controls.
Read More
Domestic manufacturers seeking policy intervention based on flawed data interpretation: MTaI
MTaI says medical device import growth is overstated using rupee data; dollar terms show modest rise, making higher customs duty demands misleading.
Read More
Reviewing package rates for AB-PMJAY essential for quality healthcare: MTaI
MTaI welcomes review of AB-PMJAY rates, urges fixing unviable packages, separating device costs, and allowing patient top-ups for quality choice.
Read More